447 related articles for article (PubMed ID: 24620626)
1. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
4. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
Weinstock LB; Geng B; Brandes SB
Can J Urol; 2011 Aug; 18(4):5826-30. PubMed ID: 21854715
[TBL] [Abstract][Full Text] [Related]
5. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients.
Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N
Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100
[TBL] [Abstract][Full Text] [Related]
6. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.
Scarpellini E; Giorgio V; Gabrielli M; Filoni S; Vitale G; Tortora A; Ojetti V; Gigante G; Fundarò C; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1314-20. PubMed ID: 23740443
[TBL] [Abstract][Full Text] [Related]
7. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
Cuoco L; Salvagnini M
Minerva Gastroenterol Dietol; 2006 Mar; 52(1):89-95. PubMed ID: 16554709
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
Lombardo L; Foti M; Ruggia O; Chiecchio A
Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
[TBL] [Abstract][Full Text] [Related]
9. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
Stoicescu A; Andrei M; Becheanu G; Stoicescu M; Nicolaie T; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):766-72. PubMed ID: 23272525
[TBL] [Abstract][Full Text] [Related]
10. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
Majewski M; McCallum RW
Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
Aziz I; Törnblom H; Simrén M
Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
[TBL] [Abstract][Full Text] [Related]
12. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.
Peralta S; Cottone C; Doveri T; Almasio PL; Craxi A
World J Gastroenterol; 2009 Jun; 15(21):2628-31. PubMed ID: 19496193
[TBL] [Abstract][Full Text] [Related]
13. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
Zhuang X; Tian Z; Luo M; Xiong L
BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214
[TBL] [Abstract][Full Text] [Related]
14. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
Ghoshal UC; Srivastava D; Misra A; Ghoshal U
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
[TBL] [Abstract][Full Text] [Related]
15. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
Ghoshal UC; Srivastava D; Ghoshal U; Misra A
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
[TBL] [Abstract][Full Text] [Related]
16. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.
Parodi A; Dulbecco P; Savarino E; Giannini EG; Bodini G; Corbo M; Isola L; De Conca S; Marabotto E; Savarino V
J Clin Gastroenterol; 2009; 43(10):962-6. PubMed ID: 19525858
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
Collins BS; Lin HC
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):382-6. PubMed ID: 21240023
[TBL] [Abstract][Full Text] [Related]
18. Rifaximin treatment for symptoms of irritable bowel syndrome.
Fumi AL; Trexler K
Ann Pharmacother; 2008 Mar; 42(3):408-12. PubMed ID: 18303148
[TBL] [Abstract][Full Text] [Related]
19. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Posserud I; Stotzer PO; Björnsson ES; Abrahamsson H; Simrén M
Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502
[TBL] [Abstract][Full Text] [Related]
20. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
Ghoshal UC; Shukla R; Ghoshal U
Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]